KOD · Kodiak Sciences
The AI's read
A share-price jump does not show what changed in Kodiak's business. This roundup gives no company news explaining the move, so it does not change how we read Kodiak.
The report says Kodiak shares rose 57.4% to $50.93 before trading. It gives no company news explaining the move, so the story does not change Kodiak's outlook.
A share-price jump does not show what changed in Kodiak's business. This roundup gives no company news explaining the move, so it does not change how we read Kodiak.
The report says Accuray shares rose 50.16% to $0.32 before trading. It gives no company news explaining the move, so the story does not change Accuray's outlook.
The report says DataMEDS AI shares rose 29.58% to $4.03 before trading. It gives no company news explaining the move, so the story does not change the company's outlook.
The report says Lakewood-Amedex shares rose 17.36% to $1.96 before trading. It gives no company news explaining the move, so the story does not change the company's outlook.
The report says Eloxx Pharma shares rose 16.1% to $17.45 before trading. It gives no company news explaining the move, so the story does not change the company's outlook.
The report says Onconetix shares rose 15.53% to $1.19. It gives no company news explaining the move, so the story does not change Onconetix's outlook.
Follow Kodiak Sciences (KOD) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KOD